検索結果一覧

一般口演 / Oral Session

一般口演 105 (Oral Session 105) :免疫制御
 
日程
2013年10月13日(日)
時間
15:00 - 16:00
会場
第13会場 / Room No.13 (札幌市教育文化会館 3F 研修室301)
座長・司会
渋谷 彰 (Akira Shibuya):1
1:筑波大学医学医療系 免疫学

前へ戻る


Clinical study of WT1 peptide vaccination for pediatric leukemia after stem cell transplantation

演題番号 : OS-3-170

橋井 佳子 (Yoshiko Hashii):1、渡辺 新 (Arata Watanabe):2、坪井 昭博 (Akihiro Tuboi):3、尾路 祐介 (Yusuke Oji):4、保仙 直毅 (Naoki Hosen):5、宮村 能子 (Takako Miyamura):1、岡 芳弘 (Yoshihiro Oka):6、大薗 恵一 (Keiichi Ozono):1、杉山 治夫 (Haruo Sugiyama):7

1:Developmental Medicine Osaka University Graduate School of Medicine, Osaka, Japan、2:Nakadoori General Hospital, Akita, Japan、3:Cancer Immunother, Osaka Univ Grad Sch Med., Osaka, Japan、4:Cancer Stem Cell Biology, Osaka Univ Grad Sch Med., Osaka, Japan、5:Biomed Inform, Osaka Univ Grad Sch Med., Osaka, Japan、6:Resp Med, Allerg Rheum Disease, Osaka Univ Grad Sch Med., Osaka, Japan、7:Func Diag Sci, Osaka Univ Grad Sch Med., Osaka, Japan

Clinical study of WT1 peptide vaccination for pediatric leukemia after stem cell transplantation

K562 based artificial antigen presenting cells inhibit T cell proliferation

演題番号 : OS-3-171

谷本 一史 (Kazushi Tanimoto):1,2、藤原 弘 (Hiroshi Fujiwara):1、Pawel Muranski:2、John A. Barrett:2、Joseph J. Melenhorst:3

1:Dept. Hematology, Clinical Immunology and Infectious Diseases, Ehime Univ., Japan、2:Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA、3:Abramson Cancer Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

K562 based artificial antigen presenting cells inhibit T cell proliferation

TLR7 ligand overcomes therapeutic resistance to GM-CSF-gene transduced tumor vaccination

演題番号 : OS-3-172

成澤 慈 (Megumi Narusawa):1、井上 博之 (Hiroyuki Inoue):1,2、坂本 千香 (Chika Sakamoto):1、井上 朋子 (Tomoko Inoue):1、宮本 将平 (Shohei Miyamoto):1、井上 誠 (Makoto Inoue):3、高山 浩一 (Koichi Takayama):2、長谷川 護 (Mamoru Hasegawa):2、中西 洋一 (Yoichi Nakanishi):2、谷 憲三朗 (Kenzaburo Tani):1

1:Molecular Clinical Genetics, Medical Institute of Bioregulation, Kyushu University, Japan、2:Research Institute for Diseases of the Chest, Fukuoka, Japan、3:DNAVEC Corporation, Tsukuba, Japan

TLR7 ligand overcomes therapeutic resistance to GM-CSF-gene transduced tumor vaccination

IFN-γ-mediated elimination of host DCs by cytokine induced killer cells leads to less GVHD

演題番号 : OS-3-173

馬瀬 新太郎 (Shintaro Mase):1、西村 良成 (Ryosei Nishimura):1、黒田 梨絵 (Rie Kuroda):1、藤木 俊寛 (Toshihiro Fujiki):1、荒木 来太 (Raita Araki):1、前馬 秀昭 (Hideaki Maeba):1、小泉 晶一 (Shoichi Koizumi):1、谷内江 昭宏 (Akihiro Yachie):1

1:Pediatrics, Kanazawa Univ., Japan

IFN-γ-mediated elimination of host DCs by cytokine induced killer cells leads to less GVHD

TLR2-dependent induction of IL-10 and Foxp3Tregs prevents Pam2 lipopeptide anti-tumor immunity

演題番号 : OS-3-174

岡田 耕平 (Kohei Okada):1、山崎 小百合 (Sayuri Yamazaki):2、丸山 晃 (Akira Maruyama):3、松本 美佐子 (Misako Matsumoto):3、八木田 秀雄 (Hideo Yagita):4、豊嶋 崇徳 (Takanori Teshima):1、瀬谷 司 (Tsukasa Seya):3

1:Department of Hematology, Hokkaido University Graduate School of Medicine、2:Department of Geriatric and Environmental Dermatology, Nagoya City University, Nagoya, Japan、3:Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan、4:Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

TLR2-dependent induction of IL-10 and Foxp3Tregs prevents Pam2 lipopeptide anti-tumor immunity